financetom
Business
financetom
/
Business
/
Top potash producer Nutrien misses fourth-quarter profit estimates on lower crop nutrient sales
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Top potash producer Nutrien misses fourth-quarter profit estimates on lower crop nutrient sales
Feb 19, 2025 3:02 PM

Feb 19 (Reuters) - Nutrien ( NTR ) fell short of Wall Street expectations for

fourth-quarter profit on Wednesday, as the top potash producer struggled with lower sales of

crop nutrients.

Quarterly sales for its retail segment were down at $3.18 billion, compared with $3.50

billion a year earlier, dragged by about 15% drop in crop nutrients sales.

The company said the sales volumes were impacted by wet weather in North America in the

quarter as well as its strategic actions in Brazil.

Earlier this month, Nutrien's ( NTR ) Brazilian unit said it would sell its fertilizer blending

plants in the country.

Nutrien ( NTR ) is shifting its focus to reselling farm inputs through its network of local

retailers in Brazil as part of a sharp strategic change after its acquisitions and investments

failed to yield the expected returns.

The Saskatoon, Canada-based firm posted an adjusted profit of 31 cents per share for the

three months ended December 31, compared with the analysts' average estimate of 35 cents per

share, according to data compiled by LSEG.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
--McDonald's, Supermarkets Failed to Spot Forced Labor of Workers, BBC Reports
--McDonald's, Supermarkets Failed to Spot Forced Labor of Workers, BBC Reports
Oct 2, 2024
07:42 AM EDT, 09/30/2024 (MT Newswires) -- Price: 303.13, Change: -0.56, Percent Change: -0.18 ...
Prime Medicine Enters Research Collaboration, License Agreement With Bristol Myers Squibb
Prime Medicine Enters Research Collaboration, License Agreement With Bristol Myers Squibb
Oct 2, 2024
07:43 AM EDT, 09/30/2024 (MT Newswires) -- Prime Medicine ( PRME ) said Monday that it has entered into a strategic research collaboration and license agreement with Bristol Myers Squibb ( BMY ) to develop reagents for the next generation of ex vivo T-cell therapies. The company said it will receive a $55 million upfront payment and a $55 million...
DirecTV clinches long-elusive deal to combine with Dish
DirecTV clinches long-elusive deal to combine with Dish
Oct 2, 2024
NEW YORK (Reuters) - DirecTV on Monday agreed to buy EchoStar's ( SATS ) satellite television business that includes Dish TV, capping decades of on-and-off talks to create one of the nation's largest pay TV distributors with a combined 20 million subscribers. The transaction comes at a time when satellite TV services DirecTV and Dish are hemorrhaging market share to competitors like...
TTEC Holdings Receives Proposal From CEO Kenneth Tuchman to Take Company Private
TTEC Holdings Receives Proposal From CEO Kenneth Tuchman to Take Company Private
Oct 2, 2024
07:43 AM EDT, 09/30/2024 (MT Newswires) -- TTEC Holdings ( TTEC ) said on Monday its Board had received an unsolicited proposal from founder and CEO Kenneth Tuchman to take the company private at a purchase price of $6.85 per share. Tuchman currently owns about 58% of the company's stock. The company said the board has established a special committee...
Copyright 2023-2026 - www.financetom.com All Rights Reserved